Sarepta Therapeutics Inc.
SRPT | NASDAQ
$18.32
-$0.30 (-1.61%)
At close: Nov 2, 2026, 4:00 PM ET
$18.39
+$0.07 (+0.38%)
After-hours:
Nov 2, 2026, 4:44 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 326.07M | 330.96M | -282.85M | -179.95M | 196.89M | -447.51M | 159.05M | 33.61M | 6.46M | 36.12M | 45.66M | -40.94M | -23.94M | -516.76M | -109.24M | -257.74M | -231.48M | -105.03M | -121.98M | -48.14M | -81.41M | -167.25M |
Depreciation & Amortization | 21M | 10.59M | 5.25M | 18.45M | 10.84M | 9.98M | 10.46M | 9.81M | 8.72M | 8.74M | 11.37M | 10.93M | 10.79M | 11.31M | 10.55M | 10.7M | 9.89M | 10.72M | 10.15M | 10.5M | 8.45M | 8.93M |
Stock-Based Compensation | 53.87M | 29.4M | 30.02M | 14.93M | 37.03M | 41.43M | 49.68M | 43.45M | 50.48M | 40.69M | 45.83M | 48.06M | 47.38M | 41.25M | 50.51M | 50.42M | 102.89M | 29.2M | 29.78M | 26.68M | 28.97M | 28.51M |
Other Working Capital | -204.62M | -309.45M | 73.91M | -77.76M | -23.35M | 11.3M | 79.92M | -73.24M | 38.27M | -290.62M | -35.8M | -28.5M | -7.37M | -52M | -42.27M | -19.02M | -4.73M | -8.6M | 6.55M | -22.01M | 16.51M | 12.91M |
Other Non-Cash Items | 36.35M | 12.62M | 39.28M | 161.21M | -32.95M | 94.44M | -2.14M | 59.06M | -5.34M | 1.98M | -7.22M | 21.95M | -109.43M | 383.86M | 7.18M | 121.67M | 6.43M | 7.45M | 5.62M | 3.58M | -95.33M | 6.73M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.21M | n/a | n/a | n/a |
Change in Working Capital | -442.91M | -586.25M | 339.51M | -29.23M | 49.53M | -281.78M | -124.99M | -216.62M | -45.38M | -329.61M | -150.29M | -154.71M | -47.03M | -129.06M | -51.39M | 9.99M | 45.45M | -43.52M | 45.9M | -116.95M | 30.17M | -57.29M |
Operating Cash Flow | -5.61M | -202.68M | 131.21M | -14.59M | 261.34M | -583.44M | 92.05M | -70.7M | 14.94M | -242.08M | -54.66M | -114.71M | -122.23M | -209.4M | -92.39M | -64.96M | -66.82M | -101.18M | -29.33M | -124.33M | -109.15M | -180.37M |
Capital Expenditures | -2.64M | -3.08M | -5.83M | -28.25M | -31.98M | -45.89M | -38.08M | -37.26M | -29.17M | -42.44M | -19.04M | -40.77M | -17.95M | -9.58M | -7.96M | -9.46M | -9.08M | -5.55M | -2.21M | -9.24M | -5.89M | -21.15M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -351.05M | -170.2M | -241.39M | 245.82M | -4.43M | -286.05M | -162.91M | -389.4M | -330.83M | -216.45M | -573.54M | -645.61M | -403.04M | -426.76M | -427.54M | -371.71M | -357.83M | -779.77M | n/a | 1K | n/a | -29.99M |
Sales Maturities Of Investments | 126.92M | 38.89M | 99.94M | 86.55M | 68.63M | 40.76M | 965.11M | 297.84M | 261.47M | 477.69M | 528.22M | 475.81M | 415.62M | 448.83M | 446.5M | 399.57M | 77.15M | n/a | n/a | 30M | 226M | 210M |
Other Investing Acitivies | -1M | -1M | 241.25M | -77.04M | -188K | -2.24M | n/a | n/a | n/a | -10M | n/a | -11.1M | 101.96M | -94K | -1.2M | -507K | -232K | -486K | -371K | -495K | 100.95M | -2.2M |
Investing Cash Flow | -227.76M | -134.39M | 96.21M | 232.4M | 32.21M | -291.18M | 764.12M | -128.83M | -98.53M | 218.8M | -64.36M | -210.57M | 96.63M | 12.49M | 9.8M | 19.12M | -289.99M | -785.81M | -2.58M | 20.27M | 321.06M | 156.67M |
Debt Repayment | n/a | n/a | -35.13M | -123.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -4.27M | -13.85M | -23.82M | 12.47M | 48.99M | 13.76M | 39.92M | 22.14M | 1.94M | 15.41M | 5.86M | 101.8M | 10.75M | 216.43M | 339K | 4.99M | 716K | 5.9M | 3.53M | 2.89M |
Financial Cash Flow | 241K | 241K | -39.21M | -117.79M | -23.82M | 12.47M | 48.99M | 13.76M | 39.92M | 22.14M | 1.94M | 15.41M | 5.86M | 101.8M | 10.75M | 216.43M | 339K | 4.99M | 549.25M | 5.9M | 3.53M | 2.89M |
Net Cash Flow | -233.13M | -336.83M | 188.21M | 100.03M | 269.73M | -862.14M | 905.16M | -185.77M | -43.67M | -1.14M | -117.07M | -309.87M | -19.74M | -95.11M | -71.85M | 170.58M | -356.47M | -881.99M | 517.35M | -98.16M | 215.44M | -20.81M |
Free Cash Flow | -8.25M | -205.76M | 125.38M | -42.83M | 229.35M | -629.33M | 53.96M | -107.96M | -14.23M | -284.52M | -73.7M | -155.48M | -140.19M | -218.98M | -100.36M | -74.42M | -75.89M | -106.73M | -31.53M | -133.57M | -115.04M | -201.52M |
Adj. Free Cash Flow | -62.12M | -235.16M | 95.36M | -57.76M | 192.33M | -670.75M | 4.29M | -151.41M | -64.71M | -325.21M | -119.52M | -203.54M | -187.57M | -260.23M | -150.87M | -124.84M | -178.79M | -135.92M | -61.31M | -160.25M | -144.01M | -230.03M |
Maintenance CapEx | -2.64M | -3.08M | -5.83M | -28.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.67M | -8.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.77M |
Growth CapEx | n/a | n/a | n/a | n/a | -31.98M | -45.89M | -38.08M | -37.26M | -29.17M | -42.44M | -19.04M | -34.1M | -9.32M | -9.58M | -7.96M | -9.46M | -9.08M | -5.55M | -2.21M | -9.24M | -5.89M | -14.38M |
Owner Earnings | -8.25M | -205.76M | 125.38M | -42.83M | 261.34M | -583.44M | 92.05M | -70.7M | 14.94M | -242.08M | -54.66M | -121.38M | -130.87M | -209.4M | -92.39M | -64.96M | -66.82M | -101.18M | -29.33M | -124.33M | -109.15M | -187.14M |
Add to Watchlist
Select watchlists to add or remove SRPT